We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Masitinib

News List

New Progress of Potential "Specific Drugs" for COVID-19: Masitinib + S2H97 PharmaSources/Chuxin
August 02, 2021
Since the outbreak of COVID-19 at the end of 2019, it has spread all over the world. Up to now, more than 190 million confirmed cases of COVID-19 have been reported worldwide, and more than 4.11 million patients have died, causing great disasters.
Existing Drug Is Shown to Inhibit Virus That Causes COVID-19 firstwordpharma
August 03, 2021
Scientists from the University of Chicago have found that the drug masitinib may be effective in treating COVID-19.
AB Science and University of Chicago to develop Covid-19 drugs pharmaceutical-technology
April 08, 2021
AB Science and the University of Chicago (UC) have signed an exclusive licensing agreement to carry out research on Covid-19 prevention and treatment with the former’s oral drug, masitinib and other drugs.